(Q44053871)

29 November 2017

title

Obesity affects myocardial vasoreactivity and coronary flow response to insulin (English)

1 reference

29 November 2017

4

1 reference

29 November 2017

7

1 reference

29 November 2017

6

Pirjo Nuutila

1 reference

29 November 2017

5

Olli Raitakari

1 reference

29 November 2017

3

Matti Luotolahti

1 reference

29 November 2017

Jan Sundell

1

1 reference

29 November 2017

Hanna Laine

series ordinal

2

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

10

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

617-624

1 reference

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Early impairment of coronary flow reserve in young men with borderline hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Insulin-induced vasodilatation: physiology or pharmacology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Influence of Cardiovascular Risk Status on Coronary Flow Reserve in Healthy Young Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Health implications of overweight and obesity in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Relation between Myocardial Blood Flow and the Severity of Coronary-Artery Stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Vascular actions of insulin in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Metabolic and hemodynamic effects of a graded intracoronary insulin infusion in normal and fat anesthetized dogs: a preliminary study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Effect of Insulin on Acetylcholine-Induced Vasodilation in Normotensive Subjects and Patients With Essential Hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Sympathetic activation in obese normotensive subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.84

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2002.84

1 reference

29 November 2017

1 reference